Robin Andrulevich
Ufficiale delle Risorse Umane presso SANA BIOTECHNOLOGY, INC.
Profilo
Robin Andrulevich is currently the Director at Washington Biotechnology & Biomedical Association and the Chief People Officer & Executive Vice President at Sana Biotechnology, Inc. In the past, Andrulevich worked as a Director at Acepodia Biotechnologies, Ltd., a Principal at Amazon.com, Inc., and as the Senior Vice President-People at Juno Therapeutics, Inc. Andrulevich completed an undergraduate degree at the University of Connecticut.
Posizioni attive di Robin Andrulevich
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Ufficiale delle Risorse Umane | 01/09/2018 |
| Washington Biotechnology & Biomedical Association | Direttore/Membro del Consiglio | 01/12/2017 |
Precedenti posizioni note di Robin Andrulevich
| Società | Posizione | Fine |
|---|---|---|
| JUNO THERAPEUTICS INC | Ufficiale delle Risorse Umane | 01/04/2018 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Direttore/Membro del Consiglio | - |
| AMAZON.COM, INC. | Corporate Officer/Principal | - |
Formazione di Robin Andrulevich
| University of Connecticut | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMAZON.COM, INC. | Retail Trade |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Robin Andrulevich